# Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

> **NCT06954610** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 500 (estimated)

## Conditions studied

- Ischemic Stroke
- Atrial Fibrillation
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Vascular Diseases
- Arrhythmias, Cardiac
- Heart Diseases
- Brain Infarction
- Brain Ischemia
- Infarction Cerebral
- Stroke
- Cardioembolic Stroke
- Ischemia

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06954610
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-04
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06954610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06954610, "Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06954610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*